Filing Details

Accession Number:
0001104659-21-153088
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-23 16:01:46
Reporting Period:
2021-12-21
Accepted Time:
2021-12-23 16:01:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Iveric Bio Inc. ISEE Pharmaceutical Preparations (2834) 208185347
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1703623 Francis David Carroll C/O Iveric Bio, Inc.
5 Penn Plaza, Suite 2372
New York NY 10001
Svp, Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-21 56,207 $15.98 48,823 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2021.
  2. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.50 to $16.15 per share on December 21, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.